• N-MYC/eIF4G1 Axis Drives Survival in inv(16) AML via CBFβ-SM

  2026-07-25

  Peramangalam et al. uncover that N-MYC, regulated by a novel enhancer, sustains inv(16) acute myeloid leukemia cell survival through eIF4G1, revealing a unique mechanism linking the CBFβ-SMMHC oncoprotein to leukemic maintenance. These findings highlight new research avenues for targeting the N-MYC/eIF4G1 axis and provide a rationale for mechanism-focused acute myeloid leukemia research.

• NVP-BGJ398 Phosphate: Optimizing FGFR Inhibition in Applied

  2026-07-24

  NVP-BGJ398 phosphate stands out as a potent pan-FGFR inhibitor, enabling robust experimental advances in both oncology and skeletal disease models. This article delivers actionable workflows, troubleshooting strategies, and translational insights drawn from recent in vivo and in vitro breakthroughs.

• Danazol (Danocrine): Mechanisms and Research Protocol Guidan

  2026-07-24

  Danazol is a synthetic steroid with weak androgenic activity and established roles in inhibition of steroidogenesis and suppression of luteinizing hormone (LH). Its mechanistic effects and applications in endocrine research, including prostate cancer studies and hypothalamic–pituitary–gonadal (HPG) axis modeling, are well documented. This article provides protocol guidance, evidence review, and clarifies common misconceptions.

• T0070907: Precision PPARγ Antagonist for Pathway Dissection

  2026-07-23

  T0070907 delivers nanomolar precision as a PPARγ antagonist, enabling researchers to dissect adipogenesis, inflammation, and cell cycle regulation with unprecedented specificity. This guide details optimized workflows, troubleshooting strategies, and translational insights informed by the latest findings on the RXRα/PPARγ/NEDD4 axis.

• Hoechst 33342 Solution (1 mg/mL): Unveiling Nuclear Staining

  2026-07-23

  Explore how Hoechst 33342 nuclear stain advances live and fixed cell imaging, with a unique focus on mitochondrial quality studies and dermal fibroblast senescence. This in-depth guide integrates recent scientific breakthroughs to inform optimal assay design.

• G418 Sulfate (Geneticin): Advanced Selection and Antiviral U

  2026-07-22

  Geneticin (G418 Sulfate) stands out as a dual-purpose tool: a gold-standard antibiotic for genetic engineering selection and a potent inhibitor of Dengue virus serotype 2. This article unpacks practical protocols, experimental best practices, and recent insights connecting protein synthesis inhibition to emerging cancer and antiviral research.

• Kanamycin Sulfate: Precision Workflows for Antibiotic Resear

  2026-07-22

  Kanamycin Sulfate, a water-soluble antibiotic from APExBIO, sets the benchmark for reproducibility in antibiotic resistance research and microbiology workflows. Unlock robust experimental protocols, troubleshoot common pitfalls, and leverage insights from recent toxin inhibition studies to advance your anti-infection research.

• Acid-Responsive Nanomedicine Remodels Pancreatic Tumor Strom

  2026-07-21

  Fu et al. introduce a multistage, acid-responsive nanomedicine engineered to restore stromal homeostasis in pancreatic ductal adenocarcinoma. By sequentially releasing stroma-modulating agents and gemcitabine, this approach overcomes chemoresistance and achieves marked tumor regression in vivo.

• OTC-Ornithine-ZBTB7A Axis in Realgar-Induced CNS Toxicity

  2026-07-21

  This study elucidates how realgar, an arsenic-containing traditional medicine, induces central nervous system (CNS) toxicity by disrupting hepatic ornithine metabolism and astrocyte glycolysis. By mapping the liver–brain axis, the work identifies ornithine accumulation and ZBTB7A-mediated metabolic repression as key mechanistic links, providing actionable insight for metabolic neurotoxicology research.

• Predictive siRNA-Drug Nanoparticle Codelivery Using Netarsud

  2026-07-20

  This study establishes a quantitative framework to predict and validate the ability of ionizable small-molecule drugs, such as Netarsudil (AR-13324), to complex and co-encapsulate siRNA in nanoparticles. The approach offers mechanistic insight and practical guidance for designing combination therapies targeting complex cellular pathways, with implications for both ocular and fibrotic disease research.

• Miltefosine’s Dual Pathway Promise for Leukopenia Recovery

  2026-07-20

  Miltefosine (hexadecyl 2-(trimethylazaniumyl)ethyl phosphate) is redefining translational hematology by targeting both the PI3K/Akt and Ras/MEK/ERK signaling axes. This article synthesizes mechanistic insights, rigorously validated experimental data, and practical protocol guidance to empower researchers tackling leukopenia and related challenges. Beyond oncology and anti-viral applications, we spotlight Miltefosine’s novel role in neutrophil differentiation and white blood cell recovery, bridging the latest evidence with strategic translational recommendations.

• Naftifine HCl: Precision Antifungal Research and Workflow Ma

  2026-07-19

  Naftifine HCl from APExBIO empowers researchers to dissect antifungal mechanisms with high-purity, workflow-ready solutions. This guide details advanced workflows, troubleshooting strategies, and integrates cutting-edge findings for reproducible, quantitative mycology experiments.

• GST-Mediated Antioxidant Defenses in M. usitatus Insecticide

  2026-07-18

  The study by Dong et al. demonstrates that glutathione S-transferase (GST) upregulation in Megalurothrips usitatus fortifies antioxidant defenses, driving resistance to the insecticide lambda-cyhalothrin. Functional inhibition of GST via diethylmaleate sharply increases insecticide sensitivity and underscores GST's central role in oxidative stress responses, offering mechanistic insights for resistance management and redox regulation studies.

• MMP-2 Responsive Liposomes for Sequential Immunotherapy Deli

  2026-07-17

  This study presents an intelligent, MMP-2-responsive liposomal system for the sequential delivery of a PD-1/PD-L1 blockade peptide and an IDO inhibitor, targeting the immunosuppressive microenvironment in breast cancer. The dual-targeting approach enhances T cell reactivation and tumor inhibition while reducing toxicity, offering a promising paradigm for combination immunotherapy.

• Ultrafiltration Enables High-Purity Circular RNA Isolation

  2026-07-17

  Guillen-Cuevas et al. introduce an ultrafiltration-based method for efficiently purifying circular RNA (circRNA) from linear RNA contaminants, achieving higher purity and yield than conventional SE-HPLC. This advance supports the scalable production of circRNA for therapeutic applications, addressing a major bottleneck in RNA bioprocessing.

16898 records 1/1127 page Next 12345 下5页 Last page